Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;26(3):567-71.
doi: 10.4014/jmb.1512.12017.

A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift

Hyeun Bum Kim  1   2 , Yuankai Wang  1   3 , Xingmin Sun  4
Affiliations

A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift

Hyeun Bum Kim et al. J Microbiol Biotechnol. 2016 Mar.

Abstract

We investigated the increased risk of Clostridium difficile infection (CDI) caused by the combined use of antibiotics and an immunosuppressive drug in a mouse model. Our data showed that an approximate return to pretreatment conditions of gut microbiota occurred within days after cessation of the antibiotic treatment, whereas the recovery of gut microbiota was delayed with the combined treatment of antibiotics and dexamethasone, leading to an increased severity of CDI. An alteration of gut microbiota is a key player in CDI. Therefore, our data implied that immunosuppressive drugs can increase the risk of CDI through the delayed recovery of altered gut microbiota.

Keywords: Antibiotics; Clostridium difficile infection; Gut; Immunosuppressive drug; Microbiota.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Clinical presentation of mice in each group
Data on survival (A), diarrhea (B), and weight loss (C) of each group of mice are shown. Mice in group 1 (G1) were not treated with anything. Mice in groups 2 and 3 (G2 and G3) were treated with antibiotics or antibiotics with dexamethasone mixture for 5 days, respectively. Then the mice were challenged with 1 × 106 spores of C. difficile UK6. The weight of mice and progression of the disease were monitored after the C. difficile challenge. G1: No antibiotics. G2: Clindamycin+antibiotics. G3: Clindamycin+antibiotics+dexamethasone.
Fig. 2
Fig. 2. Taxonomic classification of the sequences at the genus level
Phylogenetic assessments were performed using the RDP classifier implemented in QIIME with a bootstrap cutoff of 80%. Phylum, class, order, family, and genus are presented in each legend. “Other” represents the unclassified taxon at each level of classification. The antibiotics treatments were continued for 5 days between 44 and 48 days of age. G1: No antibiotics. G2: Clindamycin+antibiotics. G3: Clindamycin + antibiotics + dexamethasone.
See this image and copyright information in PMC

References

    1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920. - PubMed
    1. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4:430–435. - PubMed
    1. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7:335–336. - PMC - PubMed
    1. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135:1984–1992. - PubMed
    1. Das R, Feuerstadt P, Brandt LJ. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease. Am. J. Gastroenterol. 2010;105:2040–2049. - PubMed

Publication types

MeSH terms